X0508 4 2026-02-11 0001281895 ROCKET PHARMACEUTICALS, INC. RCKT 0002064940 Chaudhuri Sarbani C/O ROCKET PHARMACEUTICALS, INC. 9 CEDARBROOK DRIVE CRANBURY NJ 08512 true See Remarks false Common Stock 2026-02-11 4 A 0 125924 0 A 285160 D Stock Option (Right to Buy) 3.24 2026-02-11 4 A 0 189076 0 A 2036-02-11 Common Stock 189076 189076 D Holdings include Restricted Stock Units ("RSUs") that convert to common stock on a one-for-one basis. Represents RSUs, one-third (1/3) of which will become fully vested on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years. This option represents a right to purchase a total of 189,076 shares of the Issuer's common stock, one-third of which will become fully vested and exercisable on February 11, 2027, with the remaining shares vesting in equal quarterly installments over the following two years, subject to the reporting person's continued employment with the Issuer. Chief Commercial & Medical Affairs Officer /s/ Martin Wilson, as attorney-in-fact for Sarbani Chaudhuri 2026-02-13